-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Allergies and many other types of immune system-related diseases originate from the interaction of complex chemical pathways that affect the behavior, distribution, and development of cells
In order to solve this knowledge gap, a team of scientists from Japan conducted a detailed study.
The team conducted a series of detailed experiments to clarify the relationship between CCL17, pu1 and other related transcription factors and promoters at the molecular level
After using sirna to target PU.
Through further cell culture experiments and computational analysis, the research team found that IRF4 and pu1 work together to activate the transcription of TARC in dendritic cells (copying DNA fragments into RNA) through the regulatory region of the CCL17 gene
Finally, the scientists used an asthmatic mouse as a model to test the effect of pu1 inhibition in vivo
These results highlight the importance of pu1 in inflammatory processes and immune diseases, and may pave the way for new treatments
It is hoped that further research will help to further clarify the regulation and transcription pathways of CCL17, so as to have a more comprehensive understanding of the complex panorama of immune diseases